Brief: FDA Approves Abbott HIV Combo Next Assay
01/07/2026 18:21
BRIEF-FDA Approves Abbott HIV Combo Next Assay July 1 (Reuters) - FDA:
FDA: APPROVES ABBOTT HIV COMBO NEXT ASSAY UNDER 510(K) BK261345 ON JUNE 29, 2026 - WEBSITE
Further company coverage: ABT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement